Leading experts in nonalcoholic fatty liver disease (NAFLD) research and therapy explore bench to bedside therapeutic discovery and patient management approaches at this exciting conference. Faculty present recent evidence on NAFLD’s potential triggers, disease stages, biomarkers for diagnosis and disease severity, and treatments; how to effectively translate knowledge to clinical practice; and strategies to create effective multidisciplinary teams to optimize disease outcomes.
Ariel E. Feldstein, MD
Manal F. Abdelmalek, MD, MPH, FAASLD
Philip N. Newsome, MD, PhD
Elisabetta Bugianesi MD, PhD
US residents: Please review the Real ID Act regarding boarding federally regulated commercial aircrafts. Depending on your state of residence, you may need to provide a second form of identification at the airport.